News Image

Most active stocks in Thursday's session

By Mill Chart

Last update: Sep 29, 2022

Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session.

Top most active stocks

TickerChangeComment
AAPL-5.19%74.52M shares of APPLE INC (NASDAQ:AAPL) exchanged hands today. NASDAQ:AAPL is declining 5.19% today. Yesterday the company had a press release: Apple Logic Board Failure Testing.
AMD-6.61%61.25M shares of ADVANCED MICRO DEVICES (NASDAQ:AMD) exchanged hands today. The share price decreased by 6.61%.
SNTI50.36%SENTI BIOSCIENCES INC's (NASDAQ:SNTI) traded a high volume of 60.09M shares. NASDAQ:SNTI is advancing 50.36% today.
F-6.24%FORD MOTOR CO's (NYSE:F) traded a high volume of 54.18M shares. NYSE:F is declining 6.24% today. Yesterday the company had a press release: Hagens Berman: Updated Lawsuit Against Ford Shows Pattern of Reducing Roof Strength in Super Duty Trucks and Ford’s Knowledge of Risk of Grave Injury in Rollover Accidents.
TSLA-6.94%So far 52.04M shares of TESLA INC (NASDAQ:TSLA) have traded in today's session. NASDAQ:TSLA is declining 6.94% today.
BBAI30.25%So far 48.3M shares of BIGBEAR.AI HOLDINGS INC (NYSE:BBAI) have traded in today's session. Shares are rising by 30.25%. A press release (BigBear.ai Awarded $14.8 Million U.S. Army Global Force Information Management System Contract) was released earlier today.
AVCT-1.97%AMERICAN VIRTUAL CLOUD TECHN's (NASDAQ:AVCT) traded a high volume of 43.57M shares. The share price decreased by 1.97%.
PLTR0.13%PALANTIR TECHNOLOGIES INC-A's (NYSE:PLTR) traded a high volume of 42.47M shares. NYSE:PLTR is advancing 0.13% today. Earlier today the company had a press release: Investor Alert: Palantir Technologies Inc. (PLTR) Class Action - Bronstein, Gewirtz & Grossman, LLC, A Prominent Firm, Encourages Shareholders to Actively Participate.
ITUB0.2%36.26M shares of ITAU UNIBANCO H-SPON PRF ADR (NYSE:ITUB) have been traded so far today. Shares are rising by 0.2%.
SOFI-7.52%36.15M shares of SOFI TECHNOLOGIES INC (NASDAQ:SOFI) have been traded so far today. The share price decreased by 7.52%.

Our most active stocks screener will show you the full list.

Back

SENTI BIOSCIENCES INC

NASDAQ:SNTI (4/25/2024, 7:18:01 PM)

After market: 0.2787 0 (0%)

0.2787

0 (-0.78%)

SNTI News

News Imagea month ago - InvestorPlaceSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Senti Biosciences (NASDAQ:SNTI) just reported results for the fourth quarter of...

News Imagea month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
News Imagea month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

– IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second...

News Image4 months ago - Seeking AlphaSenti Biosciences to reduce workforce by 37% (NASDAQ:SNTI)

Senti Biosciences plans to cut workforce by ~37% to prioritize investment in its cell therapy for acute myeloid leukemia, SENTI-202.

News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1...

News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy data expected by year-end 2024 and durability...

News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!

SNTI Links
Follow us for more